Moderna touts its COVID vaccine’s endurance and earnings that beat expectations
Moderna Inc. said its COVID-19 vaccine remained 93% effective six months after the second shot as it reported second-quarter earnings and revenue that beat expectations.
A final analysis of the companys late-stage study, described in a statement on Thursday,…
